NCT01317433 (SKINUX) is a NA clinical trial of Doxycycline in Colorectal Cancer Metastatic, sponsored by Institut Cancerologie de l'Ouest.

Who is sponsoring NCT01317433?

NCT01317433 is sponsored by Institut Cancerologie de l'Ouest.

What drugs are being tested in NCT01317433?

Interventions in NCT01317433: Doxycycline, Cetuximab.

What condition does NCT01317433 study?

NCT01317433 studies Colorectal Cancer Metastatic, Skin Toxicity.

Is NCT01317433 still recruiting?

NCT01317433 is currently terminated. Last updated 25 March 2020.

Last reviewed 2020-03-25 · How we verify

NCT01317433: SKINUX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer

Terminated NA Last updated 25 March 2020

What this trial tests

NA trial testing Doxycycline in Colorectal Cancer Metastatic in 25 participants. Terminated before completion.

Timeline

29 December 2010

Primary endpoint
10 October 2016

10 October 2016

Quick facts

Lead sponsor	Institut Cancerologie de l'Ouest
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	29 December 2010
Primary completion	10 October 2016
Estimated completion	10 October 2016
Sites	5 locations across France

Drugs / interventions tested

Doxycycline (doxycycline) — full drug profile →
Cetuximab (cetuximab) — full drug profile →

Conditions studied

Colorectal Cancer Metastatic — all drugs for Colorectal Cancer Metastatic →
Skin Toxicity — all drugs for Skin Toxicity →

Sponsor

Institut Cancerologie de l'Ouest — full company profile →

Who can join

Adults 18 to 80, any sex, with Colorectal Cancer Metastatic or Skin Toxicity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to test the role of cycline in the prevention of acne-like skin rash in metastatic colorectal patients treated with Cetuximab and intensified FOLFIRI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Doxycycline

Trials testing the same drug.

NCT07306234 — Doxycycline vs. Macrolide for MRMP (DOMINO) · Phase 4 · not yet recruiting
NCT07230028 — Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study. · Phase 4 · not yet recruiting
NCT07343635 — The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined · NA · recruiting
NCT07164131 — Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lacta · Phase 4 · recruiting
NCT06915688 — A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations · NA · not yet recruiting

Other recruiting trials for Colorectal Cancer Metastatic

Currently open trials in the same condition.

NCT07328087 — COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer · EARLY_PHASE1 · recruiting
NCT07462650 — Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer · Phase 1, PHASE2 · recruiting
NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
NCT07172282 — INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases · EARLY_PHASE1 · recruiting
NCT06889610 — A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors. · Phase 2 · recruiting

Other Institut Cancerologie de l'Ouest trials

Trials by the same sponsor.

NCT06978296 — HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymp · NA · not yet recruiting
NCT06967987 — Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2- · Phase 2 · withdrawn
NCT06756802 — Reproductive Health in Breast Cancer Survivor · active not recruiting
NCT07007325 — Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small · EARLY_PHASE1 · not yet recruiting
NCT06994702 — Impact of the MRI Restraint System on the Quality of the Synthetic Scan for Intracranial Radiotherapy Treatment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01317433 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut Cancerologie de l'Ouest
Last refreshed: 25 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01317433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing